Local 12: Diabetes study focuses on how long blood sugar control can be maintained
The University of Cincinnati's Robert Cohen, MD, spoke with Local 12 about the GRADE study.
"This was a type two diabetes study, and whereas most studies are looking at how good the blood sugar control can be, this study was focused on how long the blood sugar control can be maintained,” said Cohen, a professor in UC's College of Medicine and UC Health endocrinologist.
Maintaining blood sugar control near normal levels can lower the risk of further complications like heart and kidney disease and vision problems for people with diabetes, Cohen said.
The years-long study found medications now known as Ozempic or Mounjaro were some of the best at maintaining long-term blood sugar control.
“That and insulin itself really did the best job of preserving glycemic blood sugar control,” Cohen said.
As the research continues, Cohen said the team will move beyond drugs that bring down blood sugar levels to evaluate drugs that preserve insulin-producing cells.
Watch or read the Local 12 story.
Featured photo at top of a semaglutide injection pen. Photo/aprott/iStock.
Related Stories
Is Cincinnati building new homes fast enough?
September 22, 2026
Gary Painter, professor and academic director of the Real Estate Center at UC's Lindner College of Business, offers comments on affordability issues in Cincinnati.
'Discovery, mentorship, momentum': UC College of Medicine's graduate programs celebrate year of success
September 22, 2026
From new mentorship honors to a growing research pipeline, see how the University of Cincinnati College of Medicine's graduate programs made this a standout year.
Tina Cheng, MD, receives American Academy of Pediatrics’ highest honor
September 22, 2026
UC Pediatrics chair Tina Cheng, MD, has received the American Academy of Pediatrics' highest honor for her decades of advancing child health.